复方黄柏液联合派瑞松对脂溢性皮炎患者皮肤组织K17和静脉血清IL-2 IL-8水平的影响

doi:10.3969/j.issn.1006-6233.2017.10.038

摘要
图/表
参考文献
相关文章 (3)

全文: PDF (1397 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要 目的: 探讨复方黄柏液联合派瑞松对脂溢性皮炎患者皮肤组织K17和静脉血清IL-2,IL-8水平的影响,并分析临床疗效。方法: 回顾性研究脂溢性皮炎患者130例,根据电脑生成的随机数字表将所有患者随机分为实验组和对照组,每组各65例,对照组患者仅使用派瑞松进行治疗,实验组患者使用复方黄柏液联合派瑞松进行治疗。比较治疗前后两组患者皮肤组织K17表达、静脉血清白介素2(IL-2)、白介素8(IL-8)水平变化,并对比两组患者治疗期间的不良反应及治疗结束后的临床疗效。结果: 与治疗前相比,两组患者K17表达水平均降低,IL-2及IL-8水平均升高(P<0.05);与对照组相比,实验组患者K17表达水平较低(P<0.05);IL-2及IL-8水平较高(P<0.05);不良反应发生率较低(P<0.05);临床总有效率较高(P<0.05)。结论: 复方黄柏液联合派瑞松对脂溢性皮炎患者具有较好的临床疗效,并能够降低不良反应发生率,推测其机制与降低皮肤组织K17表达、升高血清IL-2及IL-8水平有关。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：复方黄柏液, 派瑞松, 脂溢性皮炎, K17, IL-2, IL-8

Abstract：Objective: To investigate the effects of compound huang bai liquid combined with pevisone on the expression levels of skin tissue K17 and serum IL - 2, IL - 8 in patients with seborrheic dermatitis. Methods: 130 patients with seborrheic dermatitis from our hospital were analyzed by retrospective study, and they were divided into experiment group and control group by random number table, 65 cases in each group. Patients in the control group were only given pevisone; While, patients in the experiment group were treated by compound huang bai liquid combined with pevisone. After treatment, the expression levels of skin tissue K17 and serum interleukin 2 (IL - 2), interleukin 8 (IL - 8) levels, the adverse reactions and the clinical efficiency in patients of the two groups patients were compared. Results: Compared with before treatment, the expression levels of skin tissue K17 in patients of the two groups were significantly decreased; The expression levels of serum IL - 2 and IL - 8 significantly increased (P < 0.05); Compared with the control group, the expression level of K17 in the experiment group was lower (P < 0.05), but the serum levels of IL - 2 and IL - 8 were higher (P < 0.05). The incidence rate of adverse reactions in experiment group were significantly lower than that in control group (P < 0.05). The clinical efficacy was significantly higher in experiment group than that in control group (P < 0.05). Conclusion: Compound huang bai liquid combine with pevisone in the treatment of patients with seborrheic dermatitis has good clinical efficacy, and could significantly reduce the incidence rate of adverse reactions. We speculate that the mechanism maybe related to the decline of the expression levels of K17 and increasing the serum IL - 2 and IL - 8 levels.

Key words： Compound huang bai liquid Pevisone Seborrheic dermatitis K17 IL - 2 IL - 8

基金资助:陕西省自然科学基金项目,(编号:201200812)

引用本文:

张建珍, 张俊芳, 张燕. 复方黄柏液联合派瑞松对脂溢性皮炎患者皮肤组织K17和静脉血清IL-2 IL-8水平的影响[J]. 河北医学, 2017, 23(10): 1711-1714.
ZHANG Jianzhen, et al. Effects of Compound Huang Bai Liquid combined with Pevisone on the Expression |Levels of Skin Tissue K17 and Serum IL - 2, IL - 8 |in Patients with Seborrheic Dermatitis. 河北医学, 2017, 23(10): 1711-1714.

链接本文:

http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2017.10.038 或 http://www.hbyxzzs.cn/CN/Y2017/V23/I10/1711

[1]Schwartz J R, MESSEnGER A G, ToSTI A, et al. A comprehensive pathophysiology of dandruff and seborrheic dermatitis–towards a more precise definition of scalp health[J].Acta dermato-venereologica, 2013, 93(2): 131~137.
[2] 张蓓,贾建琴.液氮联合糠酸莫米松乳膏与氯碘羟喹治疗头皮脂溢性皮炎75例临床观察[J].中国皮肤性病学杂志,2014,28(05):548~550.
[3] Lee Y W, Lee S Y, Lee Y, et al. Evaluation of expression of lipases and phospholipases of Malassezia restricta in patients with seborrheic dermatitis[J].Annals of dermatology, 2013, 25(3): 310~314.
[4] 许雪,李红宾,黄云丽,等.花斑癣、马拉色菌毛囊炎、脂溢性皮炎马拉色菌诱发因素分析[J].皮肤病与性病,2014,36(04):187~189.
[5] Gary G. Optimizing treatment approaches in seborrheic dermatitis[J].The Journal of clinical and aesthetic dermatology, 2013, 6(2): 44~49.
[6] 姚俊,赵霞.复方黄柏液最新临床应用进展[J].中国新药杂志,2014,23(03):308~312,337.
[7] Goldust M, Rezaee E, Rouhani S. Double blind study of sertaconazole 2% cream vs. clotrimazole 1% cream in treatment of seborrheic dermatitis[J].Ann Parasitol, 2013, 59(1): 25~29.
[8] 陈海燕,吴洁贞,左金宝,等.面部脂溢性皮炎患者皮肤生理参数的研究[J].中国现代医学杂志,2014,24(21):77~79.
[9] Comert A, Akbas B, Kilic E Z, et al. Psychiatric comorbidities and alexithymia in patients with seborrheic dermatitis: a questionnaire study in turkey[J].American journal of clinical dermatology, 2013, 14(4): 335~342.
[10] Bhatia N. Treating seborrheic dermatitis: review of mechanisms and therapeutic options[J].Journal of drugs in dermatology: JDD, 2013, 12(7): 796~798.
[11] Gupta A K, Richardson M, Paquet M. Systematic review of oral treatments for seborrheic dermatitis[J].Journal of the European Academy of Dermatology and Venereology, 2014, 28(1): 16~26.
[12] 顾煜,李伟,海日古力·克比尔,等.复方黄柏液联合派瑞松治疗脂溢性皮炎的临床研究[J].现代生物医学进展,2016,16(12):2284~2286,2319.
[13] 罗彩虹.派瑞松乳膏治疗皮炎湿疹的疗效观察[J].当代医学,2014,28:31.
[14] 吴佳纹,肖生祥,任建文,等.角蛋白17在寻常性银屑病T淋巴细胞介导免疫机制中的作用研究[J].中国医学前沿杂志(电子版),2016,8(10):33~36.
[15] Misery L, Rahhali N, Duhamel A, et al. Epidemiology of dandruff, scalp pruritus and associated symptoms[J].Acta dermato-venereologica, 2013, 93(1): 80~81.
[16] Turlier V, Viode C, Durbise E, et al. Clinical and biochemical assessment of maintenance treatment in chronic recurrent seborrheic dermatitis: Randomized controlled study[J].Dermatology and therapy, 2014, 4(1): 43~59.
[17] 樊蔷薇. 他克莫司软膏治疗皮炎湿疹的疗效及对外周血Th1、Th2细胞因子水平的影响[J].医学综述,2016,22(3):596~599.